echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > In 2019, the maximum number of typical tickets for "top ten" pharmaceutical enterprises is 83.17 million

    In 2019, the maximum number of typical tickets for "top ten" pharmaceutical enterprises is 83.17 million

    • Last Update: 2019-12-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    2019, ah, it's going to be over again In 2019, the four strictest, tax verification, environmental protection verification, medical insurance negotiation, medical bribery, western medicine consistency evaluation, Chinese patent medicine limited prescription, Chinese herbal medicine pharmacopoeia standard debate, etc were not calm for the whole year In 2019, the institutional reform, the promulgation of new drug law and the new pharmacopoeia 2020 will come again; various laws and regulations will be updated in an endless stream; the whole year's understanding of new institutions and the whole year's learning In 2019, it's not easy for pharmaceutical companies, it's really not easy; how many sleepless nights for making drugs, how can outsiders experience and understand! 2020 is coming! Everybody hold on! In the end of the year, some things are still worth checking Remind yourself and remind yourself Today, let's take a look at the typical tickets in this year ( See also the monopoly of APIs Two enterprises, one in Henan and one in Hunan, are punished with 12.43 million yuan for suspected monopoly The results of tax inspection of 77 pharmaceutical enterprises have been published a lot, with fines ranging from hundreds of thousands, millions to tens of millions Select a representative: a pharmaceutical company in Henan Province, for illegally obtaining 4501 input invoices of value-added tax, with the amount of 44.16597 million, tax amount of 75.0821 million, and other illegal tax related issues, involving tax amount of 8.0972 million; impose a tax recovery of 83.1793 million (67.2055 million tax has been paid by itself) Note: as of the date of announcement, it is not known until now) and transferred to the judicial organ according to law A pharmaceutical company reported the situation of pumping waste water to the sewer due to reports from the masses After investigation and verification, the pharmaceutical company is suspected of entrusting the waste water that needs to enter the sewage treatment facilities to a company that does not have the treatment capacity for disposal in the way of avoiding supervision This behavior violates the provisions of Article 39 of the law of the people's Republic of China on the prevention and control of water pollution that "artificial recharge of groundwater shall not deteriorate the quality of groundwater." A fine of 1 million will be imposed A pharmaceutical retail Co., Ltd illegally purchased a total of about 200 varieties of Chinese herbal pieces, a total of 1536 batches The act of the party concerned engaging in the retail trade of Chinese herbal pieces without authorization beyond the business scope approved by the drug trade license violates the second paragraph of Article 17 of the measures for the supervision and administration of drug circulation, which states that "drug trade enterprises shall trade drugs within the business scope approved by the drug trade license." Regulations In view of the fact that the party refuses to cooperate in the investigation, instigates others to provide false evidence, and continues to engage in illegal business activities in secret, the market supervision bureau confiscates the seized pieces of traditional Chinese medicine; confiscates the illegal income of about 180000 yuan and a fine of 740000 yuan, totaling 930000 yuan In the name of the enterprise, a pharmaceutical Co., Ltd provides other people with qualification certificates and other convenient conditions to trade drugs It rents the drug trade license and charges "management fees" The lease lasts for more than six months There are a large number of drugs involved in the case and the value of the goods is large According to regulations, the drug regulatory department will impose "heavier punishment" on the drug enterprise, confiscate the illegal income, and impose a fine of 388280.46 yuan, totaling 517707.28 yuan A pharmaceutical company carries out online live broadcast through live broadcast platform In the live broadcast, male doctors, webcasts and TV hosts were invited to participate as guests, and props, guests and hosts were arranged on site to introduce and publicize the efficacy, use methods and efficiency of prescription drug "Viagra" In the speech interaction, there were "flirting with men, uniform temptation" and other contents At the same time, the parties involved in the live broadcast carried out the prescription drug "Viagra" seckill preferential sales activities According to statistics, more than 150000 people watched the live broadcast online The market supervision bureau pointed out that the parties' promotion, publicity and sales of prescription drug "Viagra" by using the media of online live broadcast did not meet the definition of commercial advertisement in Article 2 of the advertising law The advertisement not only seriously violates the prescription drug advertisement release regulations, but also contains other illegal contents in the live broadcast activities, such as violating the social good fashion In addition, "Viagra" (commonly known as sildenafil citrate tablets) is a prescription drug for the treatment of male erectile dysfunction, which can only be purchased and used with the doctor's prescription The second paragraph of Article 15 of the advertising law stipulates that prescription drugs can only be advertised in professional medical and pharmaceutical journals jointly designated by the health administration department of the State Council and the drug regulatory department of the State Council In other words, even if the drug is to be advertised, it cannot be promoted on the Internet, let alone broadcast Accordingly, the market supervision bureau shall order the advertisement publishers to stop publishing illegal advertisements and impose an administrative penalty of 700000 yuan According to the announcement issued by the State Food and drug administration, "somatostatin for injection" of a batch of drugs produced by a pharmaceutical enterprise, its "content determination" project does not meet the standard requirements of the Chinese Pharmacopoeia According to the pharmacopoeia standard, the content should be "90.0-110.0% of the labeled amount", but the content of this batch of products is detected beyond the upper limit (the highest is 111.8%, the lowest is 110.6%) In violation of the relevant provisions of the drug administration law of the people's Republic of China, 1040 pieces of "somatostatin for injection" in this batch that have been recalled and sealed up are confiscated; the sales income of RMB 4960 is confiscated, 094.21 yuan; a fine of 503770.4 yuan will be imposed for twice the value of the goods The two items are 9997864.61 yuan in total The unqualified items of Niuhuang Jiedu tablet of a pharmaceutical company were determined by the food and Drug Inspection Institute as [content determination], and the inspection basis was the supplementary inspection method and item approval documents 2008009 and 2008013 of the Chinese Pharmacopoeia, Volume I, 2015 and the State Food and drug administration At the same time, in the process of producing and recalling the above batches of Niuhuang Jiedu Tablets, there are also acts of improper storage of intermediate element tablets, improper handling of deviation, etc in violation of the pharmaceutical production quality management specifications and failure to timely notify the seller to stop selling and using the Niuhuang Jiedu Tablets that need to be recalled The following administrative penalties shall be imposed: 1 Warning; 2 Confiscating 4860 bottles of 170601 batches of Niuhuang Jiedu Tablets (value of goods: 76253.4 yuan); 3 Confiscating 723983.67 yuan of illegal income; 4 Fine: 2436218.4 yuan The bupleurum produced by a Chinese herbal medicine production enterprise and sold by a pharmaceutical company did not meet the requirements of the relevant standards in the first part of Chinese Pharmacopoeia (2015 Edition) After receiving the non-conforming inspection report, the production enterprise of Chinese Herbal Pieces colluded with the pharmaceutical company to forge a set of production, inspection and sales records of this batch of Chinese Herbal Pieces Chaihu, making up the production and sales volume from the original 949.88kg to 49.88kg, which was later found by law enforcement personnel when conducting peripheral inspection In view of the above illegal facts, the SFDA shall deal with them as follows: 1 The enterprises producing Chinese herbal pieces shall be confiscated 2.35kg of inferior Chinese Herbal Pieces Chaihu recalled according to law and the illegal income from selling inferior Chinese Herbal Pieces Chaihu shall be 83600 yuan In addition, a fine of 251500 yuan, three times the value of the illegal production of inferior Chinese Herbal Pieces Chaihu, shall be imposed, with a total fine of 335100 yuan 2 The illegal income of 99100 yuan from the illegal sale of Bupleurum chinense was confiscated to the pharmaceutical companies, and a fine of 298200 yuan, which was three times the value of the illegal sale of Bupleurum chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense chinense Chine Two batches of Fructus aurantii and one batch of Scutellaria baicalensis produced by a piece production enterprise are all treated as substandard drugs according to the inspection results, and the party concerned fails to fully inspect the purchased Fructus aurantii and Scutellaria baicalensis according to the legal standards According to the relevant provisions of the drug administration law of the people's Republic of China, the implementation regulations of the drug administration law of the people's Republic of China, and the drug administrative penalty discretion of a provincial food and drug administration, the provincial market supervision administration issued a penalty decision on March 29, 2019, confiscating the recalled inferior drugs and the illegal income from the sale of inferior drugs by 11361.3 yuan, and concurrently imposing a fine of 54785.9 yuan, The total amount of fines and confiscations was 66147.2 yuan, and the company was ordered to suspend production and business for 2 months According to the inquiry, the enterprise has been punished 16 times (Note: the fine amount of the enterprise is small, but there are many times; of course, in the same industry, it is definitely not the one who is punished the most times for disqualification, just choose a representative.) A medical equipment company produced 25 sterilizers and sold them to relevant organizations without obtaining the sterilizer registration certificate (Note: the old certificate has expired); the value of the goods was 2111520 yuan, and the illegal income was 4120 yuan Among them, the equipment company provided medical device registration certificate when selling sterilizer to a hospital, which was proved to be forged 1 Confiscate the illegal income of 4120 yuan; 2 Impose a fine of 20615200 yuan; 3 Impose an additional fine of 20615200 yuan The total amount of fines and confiscations is 41234520 yuan However, the punishment decision of the case was rejected by the local court, with a lighter request There is a bit of representativeness Although it happened in 2018, it's only recently noticed Let's put it here A foreign capital paid bribes and fined 3 billion yuan to non-state workers;
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.